Molecular Diagnosis of Pneumonia Using Multiplex Real-Time PCR Assay RespiFinder® SMART 22 FAST in a Group of Moroccan Infants

Table 1

General characteristics of the recruited patients (December 1, 2016, to May 31, 2018; N = 86).

Patient’s variables	n (%)	Positives cases n (%)	Negatives Cases n (%)
Gender
M	46 (53)	44 (95.7)	2 (4.3)	0.001
F	40 (47)	27 (67.5)	13 (32.5)
Age in hospitalization
10–30 days	60 (70)	50 (83)	10 (17)	0.4
>30 days–<4 months	26 (30)	21 (80)	5 (20)
Socioeconomic status
Low	39 (45)	29 (74.4)	10 (25.6)	0.1
Middle	46 (54)	41 (98.1)	5 (10.9)
High	1 (1)	1 (100)	0
Family history
Asthma	3 (3)	3 (100)	0	0.5
Eczema	2 (2)	2 (100)	0	0.6
Health history
Prematurity	14 (16)	9 (64.3)	5 (35.7)	0.04
Gastroesophageal reflux	1 (1)	1 (100)	0	0.8
Intensive care/oxygen therapy	9 (10)	4 (44.4)	5 (55.6)	0.007
Bronchopulmonary dysplasia	3 (3)	3 (100)	0	0.5
Congenital heart disease	1 (1)	1 (100)	0	0.8
Environment of the patient
Smokers at home	11 (13)	11 (100)	0	0.1
Pets at home	4 (5)	3 (75)	1 (25)	0.5
Home conditions
Airy and sunny habitat	42 (49)	36 (85.7)	6 (14.3)	0.3
Humidity	44 (51)	35 (79.5)	9 (20.5)